Nurix Cash And Short Term Investments from 2010 to 2024

NRIX Stock  USD 15.55  0.35  2.20%   
Nurix TherapeuticsInc Cash And Short Term Investments yearly trend continues to be fairly stable with very little volatility. Cash And Short Term Investments will likely drop to about 229.3 M in 2024. Cash And Short Term Investments is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. View All Fundamentals
 
Cash And Short Term Investments  
First Reported
2010-12-31
Previous Quarter
331.1 M
Current Value
229.3 M
Quarterly Volatility
128.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Nurix TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nurix main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 13.4 M or Interest Income of 13.4 M, as well as many exotic indicators such as Price To Sales Ratio of 4.8, Dividend Yield of 0.0 or PTB Ratio of 1.59. Nurix financial statements analysis is a perfect complement when working with Nurix TherapeuticsInc Valuation or Volatility modules.
  
This module can also supplement Nurix TherapeuticsInc's financial leverage analysis and stock options assessment as well as various Nurix TherapeuticsInc Technical models . Check out the analysis of Nurix TherapeuticsInc Correlation against competitors.
For more information on how to buy Nurix Stock please use our How to Invest in Nurix TherapeuticsInc guide.

Latest Nurix TherapeuticsInc's Cash And Short Term Investments Growth Pattern

Below is the plot of the Cash And Short Term Investments of Nurix TherapeuticsInc over the last few years. Short Term Investments is an account in the current assets section of Nurix TherapeuticsInc balance sheet. This account contains Nurix TherapeuticsInc investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Nurix TherapeuticsInc fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Nurix TherapeuticsInc's Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nurix TherapeuticsInc's overall financial position and show how it may be relating to other accounts over time.
Cash And Short Term Investments10 Years Trend
Slightly volatile
   Cash And Short Term Investments   
       Timeline  

Nurix Cash And Short Term Investments Regression Statistics

Arithmetic Mean138,955,587
Geometric Mean86,538,295
Coefficient Of Variation92.47
Mean Deviation120,075,771
Median39,039,000
Standard Deviation128,490,289
Sample Variance16509.8T
Range293.4M
R-Value0.83
Mean Square Error5587.6T
R-Squared0.69
Significance0.0001
Slope23,792,098
Total Sum of Squares231136.6T

Nurix Cash And Short Term Investments History

2024229.3 M
2023331.1 M
2022287.9 M
2021309.1 M
2020295.7 M
2019281.1 M
201837.7 M

About Nurix TherapeuticsInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Nurix TherapeuticsInc income statement, its balance sheet, and the statement of cash flows. Nurix TherapeuticsInc investors use historical funamental indicators, such as Nurix TherapeuticsInc's Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Although Nurix TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in Nurix TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nurix TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Nurix TherapeuticsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Nurix TherapeuticsInc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash And Short Term Investments331.1 M229.3 M
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nurix TherapeuticsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nurix TherapeuticsInc's short interest history, or implied volatility extrapolated from Nurix TherapeuticsInc options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Nurix TherapeuticsInc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nurix TherapeuticsInc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nurix Therapeuticsinc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nurix Therapeuticsinc Stock:
Check out the analysis of Nurix TherapeuticsInc Correlation against competitors.
For more information on how to buy Nurix Stock please use our How to Invest in Nurix TherapeuticsInc guide.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Nurix Stock analysis

When running Nurix TherapeuticsInc's price analysis, check to measure Nurix TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix TherapeuticsInc is operating at the current time. Most of Nurix TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Nurix TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix TherapeuticsInc's price. Additionally, you may evaluate how the addition of Nurix TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Is Nurix TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nurix TherapeuticsInc. If investors know Nurix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nurix TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.66)
Revenue Per Share
1.483
Quarterly Revenue Growth
0.307
Return On Assets
(0.29)
Return On Equity
(0.65)
The market value of Nurix TherapeuticsInc is measured differently than its book value, which is the value of Nurix that is recorded on the company's balance sheet. Investors also form their own opinion of Nurix TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Nurix TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nurix TherapeuticsInc's market value can be influenced by many factors that don't directly affect Nurix TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nurix TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nurix TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nurix TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.